1. Dr. M. A. SOFI MD; FRCP (London); FRCPEdin; FRCSEdin
MYOCARDITIS
Dr. M. A. SOFI
MD; FRCP (London); FRCPEdin; FRCSEdin

2. Myocarditis
Myocarditis is an inflammatory disease of the myocardium with a wide range of clinical presentations, from subtle to devastating.
Clinical features of myocarditis:
Myocarditis should be suspected in patients with or without cardiac signs and symptoms, who present with:
Rise in cardiac biomarker levels
Change in electrocardiogram suggestive of acute myocardial injury
Arrhythmia
Abnormalities of ventricular systolic function 

3. Signs and symptoms
Manifests in an otherwise healthy person with rapidly progressive (and often fatal) heart failure and arrhythmia.
Chest pain: Mild symptoms of chest pain (in concurrent pericarditis), fever, sweats, chills, dyspnea.
Mimic myocardial ischemia and/or MI symptomatically and on the ECG particularly in younger patients 
Recent history (≤1-2 wk) of flulike symptoms of fevers, arthralgias, and malaise or pharyngitis, tonsillitis, or upper respiratory tract infection in viral myocarditis

4. Palpitations: Number of arrhythmias may be seen.
Signs and symptoms
Manifests in an otherwise healthy person with rapidly progressive (and often fatal) heart failure and arrhythmia.
Palpitations: Number of arrhythmias may be seen.
Sudden cardiac death: due to underlying ventricular arrhythmias or atrioventricular block (especially in giant cell myocarditis)
Heart failure: Many cases of postviral or lymphocytic myocarditis present with heart failure and dilated cardiomyopathy.
Rapidly evolving diffuse, severe myocarditis can result in acute myocardial failure and cardiogenic shock.

5. Clinical features of myocarditis
Excessive fatigue or exercise intolerance
Partial or complete heart block, new-onset bundle branch block
Chest pain
New onset or worsening heart failure
Unexplained sinus tachycardia
Acute pericarditis
S3, S4, or summation gallop
Cardiogenic shock
Abnormal electrocardiogram
Sudden cardiac death
New cardiomegaly on chest x-ray
Hepatomegaly
Atrial or ventricular arrhythmia

6. Diagnostic evaluation: The diagnostic evaluation of patients with suspected myocarditis should include:
History/physical examination
Electrocardiogram (ECG)
Cardiac biomarkers
Chest radiograph.
Brain natriuretic peptide (BNP)
An echocardiogram.
Cardiovascular magnetic resonance (CMR) imaging may provide supportive evidence of myocarditis.
In selected patients cardiac catheterization may aid determination of hemodynamic status.
Coronary angiography in selected patients with clinical findings of acute coronary syndrome.
Potential indications for endomyocardial biopsy (EMB)

7. Testing Laboratory studies of myocarditis may include: CBC
Diagnostic work up
Testing
Laboratory studies of
myocarditis may include:
CBC
ESR/C-reactive protein
Rheumatologic screening
Cardiac enzyme (creatine kinase or cardiac troponins)
Serum viral antibody titers
Viral genome testing in endomyocardial biopsy
Electrocardiography
Imaging studies
Echocardiography: To exclude causes of heart failure ( amyloidosis or valvular or congenital)
Antimyosin scintigraphy: To identify myocardial inflammation
Cardiac angiography: To rule out IHD
Gadolinium-enhanced MRI: To assess extent of inflammation and cellular edema; nonspecific

8. Sequential chest radiographs in myocarditis
PA view sequential chest radiographs in a young man with acute myocarditis (left). Cardiomegaly and pulmonary congestion are apparent. Three months later, the lungs have cleared but the patient has developed dilated cardiomyopathy with persistent cardiomegaly.

9. Cardiovascular magnetic resonance images of coxsackievirus-induced myocarditis
Cardiovascular magnetic resonance images of a 58-year-old woman with coxsackievirus-induced myocarditis and ventricular tachycardia. Late gadolinium enhancement is seen in a basal to mid anterior and anterolateral distribution (arrows). Note the epicardial to transmural distribution of the enhancement, which is more consistent with myocarditis than myocardial infarction.

10. Causes: Immunologic: Drugs: Ethanol, Anthracyclines Chemotherapy
Antipsychotics, e.g. clozapine
Mephedrone
Physical agents
Electric shock
Hyperpyrexia, and radiation
Heavy metals
(copper or iron)
Toxins: (arsenic, toxic shock syndrome, carbon monoxide, or snake venom)
Immunologic:
Acetazolamide
Heart Transplant Rejection
Autoantigens :
Scleroderma
Systemic lupus erythematosus
Sarcoidosis
Churg-Strauss syndrome
Wegener's granulomatosis,
Kawasaki disease

11. Diagnosis: Usually presumptive
Diagnosis: Usually presumptive. Because many cases are not clinically obvious, a high degree of suspicion is required.
Acute rheumatic fever: Usually associated signs, such as chorea, erythema marginatum, polyarthralgia.
Hypersensitive/eosinophilic myocarditis: Pruritic maculopapular rash and history of using drug
Peripartum cardiomyopathy - Heart failure developing in the last month of pregnancy or within 5 months following delivery
Myocarditis usually present with acute heart failure and, in those with pericarditis, with pericardial friction rub.
Specific findings in special cases are:
Sarcoid myocarditis: Lymphadenopathy, also with arrhythmias, sarcoid involvement in other organs (up to 70%)

12. Procedures
Endomyocardial biopsy is the standard tool for diagnosing myocarditis.
Routine endomyocardial biopsy for diagnosis of myocarditis rarely is helpful clinically.
Histologic diagnosis seldom has an impact on therapeutic strategies, unless giant cell myocarditis is suspected

13. Management
In improving cardiac hemodynamics in heart failure, as well as providing supportive therapy, with the hope of prolonging survival.
Vasodilators :
Nitroglycerin
Sodium nitroprusside.
ACEI (Enalapril)
Diuretics (Furosemide)
Anticoagulation may be advisable as a preventive measure
Antiarrhythmics can be used cautiously, although most antiarrhythmic drugs have negative inotropic effects that may aggravate heart failure
Inotropic drugs (dobutamine, milrinone) may be necessary for severe decompensation, they are highly arrhythmogenic

14. Non-pharmacotherapy Surgical option Surgical intervention in
Supportive care in patients
with myocarditis includes:
Hemodynamic and cardiac monitoring
Administration of supplemental oxygen
Fluid management
Surgical option
Surgical intervention in
myocarditis may include:
Temporary trans-venous pacing for complete heart block
Cardiac transplantation
Extreme cases:
Ventricular assist device or percutaneous circulatory support
Left ventricular assistive devices (LVADs)
Extracorporeal membrane oxygenation

15. THANK
YOU
FOR
YOUR
ATTENTION